BioSpace News Archive

Clover Biopharmaceuticals, Ltd., a global clinical-stage biotechnology company developing novel vaccines and biologic therapeutic candidates, announced new positive clinical data in individuals vaccinated with a third dose of SCB-2019 as a homologous booster against the Omicron variant.

Amcor, a global leader in developing and producing responsible packaging solutions, announced the next phase of its inaugural Amcor Lift-Off initiative.

Relay Therapeutics, Inc. a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies, will announce the anticipated registrational path for RLY-4008 and three new programs within a growing HR+/HER2- breast cancer franchise at a virtual analyst and investor event from 8:00 a.m. to 9:00 a.m. ET.

SwanBio Therapeutics, a gene therapy company advancing AAV-based therapies for the treatment of devastating, inherited neurological conditions, today presented details about the company’s ongoing natural history study of adrenomyeloneuropathy (AMN) at the 8th Congress of the European Academy of Neurology (EAN) in Vienna.

Takeda and Arrowhead Pharmaceuticals Inc. announced that results from a Phase 2 clinical study of investigational fazirsiran for the treatment of liver disease associated with alpha-1 antitrypsin deficiency were recently published in the New England Journal of Medicine and presented in an oral presentation at The International Liver Congress™ 2022 - The Annual Meeting of the European Association for the Study of the Liver.

TCR2 Therapeutics Inc. announced the appointment of Eric Sullivan as Chief Financial Officer where he will be responsible for leading all aspects of financial management and capital market strategy as well as overseeing investor relations and select business operations.

Incannex Healthcare Limited will present an overview of progress achieved in Incannex’s psychedelic medicine program at the H.C. Wainwright First Annual Mental Health Conference, taking place June 27, 2022.

Tango Therapeutics , Inc. (NASDAQ: TNGX), a biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, today announced that the company was added to the Russell 2000 ® , Russell 3000 ® and Russell Microcap ® Indexes, effective after the U.S. market closed on June 24, 2022, as part of the 2022 Russell indexes annual reconstitution.

The Canadian Dermatology Association is pleased to announce the appointment of Dr. Jennifer Beecker to the position of CDA President, effective June 26, 2022.

Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company” or “Kraig Labs”), the biotechnology company focused on the development and commercialization of spider silk, announces that, in collaboration with its joint venture partner, Kings Group, the Company has selected a high-quality garment manufacturer to produce Spydasilk’s TM first apparel line.